mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
7e-13 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
2e-11 |
mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
0.2 |
4e-11 |
mRNA |
Camptothecin |
GDSC1000 |
pan-cancer |
AAC |
0.21 |
7e-10 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-09 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-09 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-09 |
mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
4e-09 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
8e-09 |
mRNA |
SN-38 |
GDSC1000 |
pan-cancer |
AAC |
0.19 |
9e-09 |